中国感染与化疗杂志
中國感染與化療雜誌
중국감염여화료잡지
CHINESE JOURNAL OF INFECTION AND CHEMOTHERAPY
2014年
4期
334-337
,共4页
刘明涛%李凯述%闫鹏鹏%王新安%欧阳修河
劉明濤%李凱述%閆鵬鵬%王新安%歐暘脩河
류명도%리개술%염붕붕%왕신안%구양수하
鲍曼不动杆菌%氨基糖苷类%耐药突变选择窗%联合用药
鮑曼不動桿菌%氨基糖苷類%耐藥突變選擇窗%聯閤用藥
포만불동간균%안기당감류%내약돌변선택창%연합용약
Acinetobacterbaumannii%aminoglycoside%mutant selective window%combination therapy
目的:探讨氨基糖苷类药物与其他抗鲍曼不动杆菌药物联合应用时,在缩小抗菌药物对鲍曼不动杆菌的耐药突变选择窗的作用。方法选择阿米卡星、妥布霉素及奈替米星3种氨基糖苷类药物,同时选择4种临床常用的抗鲍曼不动杆菌药物:头孢哌酮-舒巴坦、亚胺培南-西司他丁、环丙沙星及左氧氟沙星进行试验。应用 E试验法测定4种抗鲍曼不动杆菌药物和3种氨基糖苷类药物对鲍曼不动杆菌 ATCC19606的 MIC;琼脂平皿稀释法测定4种抗鲍曼不动杆菌药物单药及联合3种氨基糖苷类药物后对鲍曼不动杆菌 ATCC19606的防耐药突变浓度,计算选择指数,根据联合前后选择指数的变化,观察氨基糖苷类药物和其他抗菌药物联合后对其耐药突变选择窗的影响。结果头孢哌酮-舒巴坦、亚胺培南-西司他丁、环丙沙星、左氧氟沙星单药对鲍曼不动杆菌 ATCC19606的选择指数分别为:16、>32、16、32;联合阿米卡星后其选择指数分别为:1、2、4、4;联合妥布霉素后其选择指数分别为:2、2、8、8;联合奈替米星后其选择指数分别为:2、4、8、16。结论4种抗鲍曼不动杆菌药物在分别联合3种氨基糖苷类药物后,对鲍曼不动杆菌的耐药突变选择窗明显缩小,可以有效减少耐药突变株产生,以联合阿米卡星后的作用最为明显。
目的:探討氨基糖苷類藥物與其他抗鮑曼不動桿菌藥物聯閤應用時,在縮小抗菌藥物對鮑曼不動桿菌的耐藥突變選擇窗的作用。方法選擇阿米卡星、妥佈黴素及奈替米星3種氨基糖苷類藥物,同時選擇4種臨床常用的抗鮑曼不動桿菌藥物:頭孢哌酮-舒巴坦、亞胺培南-西司他丁、環丙沙星及左氧氟沙星進行試驗。應用 E試驗法測定4種抗鮑曼不動桿菌藥物和3種氨基糖苷類藥物對鮑曼不動桿菌 ATCC19606的 MIC;瓊脂平皿稀釋法測定4種抗鮑曼不動桿菌藥物單藥及聯閤3種氨基糖苷類藥物後對鮑曼不動桿菌 ATCC19606的防耐藥突變濃度,計算選擇指數,根據聯閤前後選擇指數的變化,觀察氨基糖苷類藥物和其他抗菌藥物聯閤後對其耐藥突變選擇窗的影響。結果頭孢哌酮-舒巴坦、亞胺培南-西司他丁、環丙沙星、左氧氟沙星單藥對鮑曼不動桿菌 ATCC19606的選擇指數分彆為:16、>32、16、32;聯閤阿米卡星後其選擇指數分彆為:1、2、4、4;聯閤妥佈黴素後其選擇指數分彆為:2、2、8、8;聯閤奈替米星後其選擇指數分彆為:2、4、8、16。結論4種抗鮑曼不動桿菌藥物在分彆聯閤3種氨基糖苷類藥物後,對鮑曼不動桿菌的耐藥突變選擇窗明顯縮小,可以有效減少耐藥突變株產生,以聯閤阿米卡星後的作用最為明顯。
목적:탐토안기당감류약물여기타항포만불동간균약물연합응용시,재축소항균약물대포만불동간균적내약돌변선택창적작용。방법선택아미잡성、타포매소급내체미성3충안기당감류약물,동시선택4충림상상용적항포만불동간균약물:두포고동-서파탄、아알배남-서사타정、배병사성급좌양불사성진행시험。응용 E시험법측정4충항포만불동간균약물화3충안기당감류약물대포만불동간균 ATCC19606적 MIC;경지평명희석법측정4충항포만불동간균약물단약급연합3충안기당감류약물후대포만불동간균 ATCC19606적방내약돌변농도,계산선택지수,근거연합전후선택지수적변화,관찰안기당감류약물화기타항균약물연합후대기내약돌변선택창적영향。결과두포고동-서파탄、아알배남-서사타정、배병사성、좌양불사성단약대포만불동간균 ATCC19606적선택지수분별위:16、>32、16、32;연합아미잡성후기선택지수분별위:1、2、4、4;연합타포매소후기선택지수분별위:2、2、8、8;연합내체미성후기선택지수분별위:2、4、8、16。결론4충항포만불동간균약물재분별연합3충안기당감류약물후,대포만불동간균적내약돌변선택창명현축소,가이유효감소내약돌변주산생,이연합아미잡성후적작용최위명현。
Objective To explore the effect of combination therapy of aminoglycosides with other antibiotics on reducing the mutant selective window of Acinetobacter baumannii. Methods Three aminoglycoside antibiotics (amikacin, tobramycin, netilmicin)and four frequently used antibiotics against Acinetobacter baumannii in clinical practice (cefoperazone-sulbactam, imipenem-cilastatin,ciprofloxacin and levofloxacin)were studied.The minimum inhibitory concentrations of these antibiotics against Acinetobacter baumannii ATCC1 9606 were determined by E-test.The mutant prevention concentrations of the four antibiotics against Acinetobacter baumannii alone or in combination with aminoglycosides were determined by agar dilution method.The selective index was calculated. The effect of aminoglycosides on mutant selective window of Acinetobacter baumannii was evaluated according to the change of selective index after combination. Results The selective index of cefoperazone-sulbactam,imipenem-cilastatin,ciprofloxacin and levofloxacin against A.baumannii ATCC19606 was 16,>32, 16 and 32.When combined with amikacin,the selective index was 1,2,4 and 4,respectively.When combined with tobramycin,the index was 2,2,8 and 8,respectively.When combined with netilmicin,the index was 2,4,8 and 16, respectively. Conclusions The mutant prevention concentration of the four antibiotics against Acinetobacter baumannii is significantly reduced when combined with any of the three aminoglycosides,which is helpful to decrease the incidence of mutants and control resistant Acinetobacter baumannii. Amikacin-based combination shows the most evident effect on reducing the mutant selective window of Acinetobacterbaumannii.